Carswell, C.
Brown, J. V. E.
Lister, J.
Ajjan, R. A.
Alderson, S. L.
Balogun-Katung, A.
Bellass, S.
Double, K.
Gilbody, S.
Hewitt, C. E.
Holt, R. I. G.
Jacobs, R.
Kellar, I.
Peckham, E.
Shiers, D.
Taylor, J.
Siddiqi, N.
Coventry, P.
,
Article History
Received: 20 April 2022
Accepted: 30 June 2022
First Online: 19 July 2022
Declarations
:
: The study was approved by the North West – Greater Manchester West Research Ethics Committee (REC reference: 18/NW/0603). Voluntary informed consent was obtained from all participants. This study was conducted in compliance with the Declaration of Helsinki.
: Not applicable
: DS is an expert advisor to the NICE Centre for Guidelines; the views expressed are the authors’ and not those of NICE. RIGH has received honoraria for speaker engagement, conference attendance or advisory boards from: Abbott, AstraZeneca, Boehringer-Ingelheim, European Association for the Study of Diabetes, Eli Lilly, Encore, Janssen, Menarini, NAPP, Novo Nordisk and Omniamed, Roche and Sanofi. PC and SG are part funded by the UK Research and Innovation Closing the Gap Network+ [ES/S004459/1] and the NIHR Applied Research Collaboration Yorkshire and Humber.